WRF
SGYP

Waddell & Reed Financial’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Waddell & Reed Financial’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-294,300
Closed -$1.67M – 655
2015
Q4 		$1.67M Hold
294,300
– – ﹤0.01% 602
2015
Q3 		$1.56M Buy
+294,300
New +$2.28M ﹤0.01% 596

Other funds holding SGYP

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Waddell & Reed Financial's SGYP Position: Q1 2016 in Review

Waddell & Reed Financial sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2016, closing a stake of 294,300 shares — an estimated $1.67M sold.

Waddell & Reed Financial first reported a position in SGYP in Q3 2015 and held it in 2 quarters. The position peaked at $1.67M in Q4 2015. 128 funds tracked by Wall St. Rank hold SGYP as of Q1 2016.

  • Waddell & Reed Financial reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2016 after selling out during the quarter.
  • Waddell & Reed Financial sold 294,300 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2016, an estimated $1.67M.
  • Waddell & Reed Financial first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2015 and held it in 2 quarters.
  • Waddell & Reed Financial's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.67M in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2016.

Based on Waddell & Reed Financial's 13F filing for Q1 2016, filed 13 May 2016.